| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP &General Counsel | EVP &General Counsel
1 company
Mahon Paul A is an EVP &General Counsel at UNITED THERAPEUTICS Corp. Recent SEC Form 4 filings include 0 buys and 38 sells.
Estimated insider holdings value: $20.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 16, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $249.15 | $1,494,921.52 | -3.1% | -14.0% | -14.6% | |
| Feb 2, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $254.63 | $1,527,793.64 | -5.1% | -15.8% | -17.8% | |
| Jan 19, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $258.95 | $1,553,683.20 | -5.0% | -12.8% | -16.2% | |
| Jan 5, 2023 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $273.82 | $1,642,914.84 | -5.0% | -15.0% | -16.3% | |
| Dec 15, 2022 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 12,000 | $196.31 | $2,355,721.65 | -5.0% | -21.2% | -10.7% | |
| Dec 1, 2022 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $277.65 | $1,665,875.82 | -3.0% | -11.1% | -12.7% | |
| Nov 17, 2022 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $259.05 | $1,554,295.69 | -3.8% | -4.3% | -13.5% | |
| Nov 3, 2022 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $257.08 | $1,542,494.10 | -3.7% | -2.0% | -15.4% | |
| Oct 20, 2022 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $216.68 | $1,300,078.29 | -4.9% | +20.3% | +4.4% | |
| Oct 6, 2022 | UTHR United Therapeutics Corp | EVP &General Counsel | Sale+OE | 6,000 | $209.26 | $1,255,560.84 | -7.3% | +30.0% | +11.7% |